Current therapeutic strategies in connective tissue disease-related interstitial lung disease: introduction to the special issue

Drugs in Context

article

Gian Luca Erre¹  Arduino Aleksander Mangoni³ 

[1] Dipartimento di Scienze Mediche, Chirurgiche e sperimentali, Università degli Studi di Sassari;Dipartimento di Specialità Mediche, Azienda Ospedaliero-Universitaria di Sassari;Discipline of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre

关键词: connective tissue diseases;    cyclophosphamide;    interstitial lung diseases;    mycophenolate;    nintedanib;    pierfenidone;    rituximab;   

DOI  :  10.7573/dic.2020-12-1

学科分类：社会科学、人文和艺术（综合）

来源: C S F Medical Communications Ltd.

【 摘 要 】

This Editorial introduces the Special Issue on the efficacy and safety of current treatment strategies for patients with connective tissue disease-related interstitial lung disease, including the use of immunosuppressants, such as cyclophosphamide, mycophenolate mofetil and rituximab, and antifibrotic drugs.

【 授权许可】

CC BY-NC-ND